Asset Licensing Potential Allied BioScience’s closure may create an opportunity to license, acquire, or co-develop SurfaceWise2 and related intellectual property. The EPA-approved antiviral coating has potential applications across healthcare, education, hospitality, and industrial facilities, offering a ready-to-market asset for a buyer or partner with existing distribution. Engage with prospective buyers to explore asset sale or licensing terms.

Channel Partners Opportunity The company previously worked with Solid Surface Care, UG2, and APEX Group to deploy SurfaceWise2, suggesting established distribution channels that may still be active or lend themselves to licensing or rebranding. Reach out to these partners to assess interest in continued selling rights, joint ventures, or contract manufacturing for renewed surface protection offerings.

Leadership Network C-suite transition and leadership involvement (CFO David Maxwell and sports marketing advisor Daryl Johnston) indicate a network with potential to facilitate introductions to investors, licensees, or strategic buyers looking to enter or re-enter the antiviral surface market.

Market Demand Alignment The market for long-lasting antiviral coatings remains relevant for facilities managers in healthcare, education, hospitality, and manufacturing; a business development plan could reframe SurfaceWise2 concepts for a new entrant or existing players seeking EPA-registered, durable disinfection solutions.

IP Landscape Past IP disputes underscore the competitive IP landscape in antiviral coatings; a due diligence and licensing oriented approach could position a partner to pursue talks with large incumbents such as STERIS, 3M, or Ecolab to scale or integrate a proven coating technology.